Pfizer is testing its vaccine against new COVID-19 strain
Drugmaker said it could develop a vaccine for the Omicron variant in 100 days, but government clearance could take longer.
Watch CBS News
Drugmaker said it could develop a vaccine for the Omicron variant in 100 days, but government clearance could take longer.
Coronavirus cases are rising in more than 30 states ahead of Thanksgiving. It comes as the White House reports about 3 million Americans received a third dose over the weekend following the FDA's authorization of both Moderna and Pfizer's booster for all adults. Vice Dean of Johns Hopkins University's Bloomberg School of Public Health Dr. Joshua Sharfstein joined CBSN's Elaine Quijano to discuss.
U.S. health officials authorized the Pfizer, Moderna and Johnson and Johnson COVID-19 booster shots for all adults. Justin Lowenthal of Doctors for America joins CBSN's Lana Zak to discuss more.
The CDC has signed off on COVID-19 booster shots for all adults. Those 18 and older can now get an additional dose of either the Pfizer or Moderna vaccine. David Begnaud has more.
Federal health officials are endorsing both Pfizer and Moderna vaccine boosters for anyone over the age of 18 as COVID-19 cases surge in new hotspots around the U.S. Dr. Lauren Hughes, an associate professor of family medicine at the University of Colorado, shares the details with CBSN anchor Lana Zak.
The pharmaceutical giant has asked the federal regulators to authorize the experimental pill, called Paxlovid.
The Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine booster shot for all adults in the U.S. as soon as this week. Pfizer is also seeking emergency-use authorization for its COVID antiviral pill. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
The FDA and CDC could expand eligibility of the Pfizer booster shot as early as this week. The drugmaker is also seeking emergency use authorization for its COVID-19 antiviral pill, Paxlovid. CBS News' Naomi Ruchim reports, and then Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, joins CBSN's Tanya Rivero to discuss the latest progress in the fight against the coronavirus pandemic.
The drugmaker filed for emergency use authorization last week.
The drugmaker is asking regulators to authorize its experimental coronavirus pill for people with mild to moderate infections.
Pfizer is requesting FDA authorization of its antiviral COVID-19 pill. The company's study found it is nearly 90% effective in cutting hospitalizations and deaths from the virus. Meanwhile, at least 20 states are experiencing upticks in infections. Infectious disease physician at the University of Michigan Dr. Payal Patel joins CBSN's Elaine Quijano to discuss the latest pandemic news.
The deal with a U.N.-backed group could make the treatment available to more than half of the world's population.
The CDC reports over 1 million children ages 5 to 11 have received the first dose of Pfizer's pediatric vaccine. This comes as several states and New York City begin expanding booster eligibility to all adults. Director of vaccine research at Cincinnati Children's Hospital, Dr. Robert Frenck, joins CBSN's Elaine Quijano with a look at the day's pandemic news.
The White House says hundreds of thousands of children aged 5 to 11 have already received their first shot of Pfizer's low dose coronavirus vaccine. CBS News correspondent Michael George reports on the latest from New York City. Then, Dr. Mark Kline, physician-in-chief at Children's Hospital New Orleans, joins CBSN's Lana Zak to discuss.
Pfizer is asking the FDA to authorize use of its COVID-19 booster shot for all U.S. adults age 18 and over. Meanwhile, the vaccine rollout of the lower-dose Pfizer vaccine for kids ages 5 to 11 is underway. Dr. Susannah Hills, a pediatric airway surgeon, joined CBSN to discuss the latest coronavirus headlines.
Pfizer submitted a request Tuesday to amend the FDA emergency use authorization for a booster dose of its COVID-19 vaccine to include all individuals 18 and older. U.S. Surgeon General Dr. Vivek Murthy joins "CBS Mornings" to discuss the latest on booster shots and vaccines for kids ages 5 to 11.
Pfizer has asked the FDA to authorize its COVID-19 vaccine booster shots for Americans 18 and older. As CBS News' Nikki Battiste reports, a third dose has only been authorized for those who are 65 and older or at high risk for the virus. Then, Dr. Angela Myers, director of the infectious diseases division at Children's Mercy Kansas City, joins CBSN's Elaine Quijano to discuss the latest on the pandemic.
Pfizer asked the FDA to authorize booster doses of its COVID-19 vaccine for all adults, ages 18 and older. Right now, it's only authorized for seniors and high-risk adults. Nikki Battiste has the latest.
Pfizer says its antiviral COVID-19 pill is 89% effective at prevent hospitalizations and 100% effective against deaths from the virus if taken within three days of a person experiencing symptoms. Dr. John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the potentially life-saving drug.
Pfizer and Merck have both developed antiviral pills that could help reduce the risk of hospitalization or death from COVID-19. Dr. Giridar Malyah, senior policy officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the latest on the coronavirus pandemic.
Ella Conrad's mom started listening to doctors and following the science — going from a QAnon follower to a vaccine advocate for her state.
Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible.
The Biden administration is requiring all companies with more than 100 employees to be fully vaccinated or be subject to weekly COVID-19 testing. The mandate comes as millions of children aged 5 to 11 are lining up to get their low dose vaccine. Assistant emergency medicine professor at St. Joseph's Regional Center Dr. Anand Swaminathan joined CBSN's Lana Zak to discuss.
Every school-age child in the U.S. is now eligible for COVID-19 shots after Pfizer's mini dose received the green light from the Centers for Disease Control and Prevention. Janet Shamlian takes a look.
The CDC unanimously recommended Pfizer's low dose COVID-19 vaccine for kids ages 5 to 11. Drugstores like CVS and Walgreens are already setting up appointments, but some parents are hesitant about getting their kids vaccinated. Family medicine physician and CEO of CFP Physicians Group Dr. Adrian Burrowes joins CBSN's Lana Zak to discuss.